Melanoma: win the battle against your resistance

In the past years, we have drastically improved treatments for melanoma-skin cancer patients. Nevertheless, tumor recurrence still remains an highly lethal matter of our concern.   I’m pursing my PhD project in the melanoma genomics lab-group of Göran Jönssön, where we are specifically working with melanoma cells invulnerable towards current effectiveRead More

15th Annual Joint GenoMEL/BioGenoMEL/MELGEN Scientific Meeting 2018

From the 20th to the 22nd March 2018 the MELGEN Consortium joined forces with the GenoMEL and BioGenoMEL consortia to hold their annual scientific meeting, this year hosted by the University Hospital Essen in Germany. In contrast to last year’s sun and high temperatures, the start of this year’sRead More

Outreaching epigenetics in melanoma at University of Helsinki

It was a great pleasure for me to represent MELGEN ESRs at the in Helsinki this year. This is an organized series arranged by the Institute for Molecular Medicine Finland (FIMM) and the Centre for Genomic Regulation (CRG’s joint EU-LIFE) to bridge clinical and basic/translational research. It also aims to provide examples of howRead More

14th Annual Joint GenoMEL/BioGenoMEL/MELGEN Scientific Meeting 2017

From the 15th to the 17th May 2017, the MELGEN researchers, together with their group leaders, will be gathering in Camogli, Italy to attend the 14th annual scientific meeting of the GenoMEL, BioGenoMEL and MELGEN consortia. Founded in 1997, the GenoMEL consortium was formed by a number of melanomaRead More

Can we trick melanoma? Unveiling novel solutions to relapse.

Cancer is a heterogeneous disease. However, it has some common features across the different existing types. One of those is relapse. Relapse is defined as “to fall back into the state of illness after apparent recovery”. Every day, researchers are trying to understand why and how cancer returns, andRead More

Leeds University welcomes ESRs

This year annual GenoMEL scientific meeting was held in Leeds, UK in April and 17 MELGEN Early Stage Researchers (ESRs) who are spread across Europe joined 60 other delegates to find out about the latest melanoma research. During the meeting PhD students presented their projects and preliminary data duringRead More